Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864)
Financial statement report of 2021
1、 Audit of the company’s financial statements in 2021
Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) (hereinafter referred to as “the company”) audited by Lixin Certified Public Accountants (special general partnership) and issued an audit report (xksbz [2022] No. zf10476). The audit found that the company’s financial statements were prepared in accordance with the accounting standards for business enterprises in all major aspects, It fairly reflects the financial position of the consolidated and parent company as of December 31, 2021, and the operating results and cash flow of the consolidated and parent company in 2021.
2、 Main financial indicators
Unit: 10000 yuan
Increase or decrease of the project from 2021 to 2020 over the previous year
Operating income 88748496703130 32.40%
Net profit attributable to shareholders of listed companies 931699791150 17.77%
Deduction attributable to shareholders of listed companies is not 936149723814 29.34%
Net profit of recurring profit and loss
Net cash flow from operating activities 11 Beijing Changjiu Logistics Corp(603569) 22380 25.80%
Basic earnings per share (yuan / share) 1.09 0.92 18.48%
Diluted earnings per share (yuan / share) 1.09 0.92 18.48%
Weighted average return on net assets 12.41%, 11.37%, 1.04%
Increase or decrease at the end of 2021 and 2020 compared with the end of the previous year
Total assets 1330174611625488 14.42%
Net assets attributable to shareholders of listed companies 79138477207770 9.80%
3、 Financial position as of December 31, 2021
At the end of 2021, the total assets of the company were 13301746 million yuan, a year-on-year increase of 14.42%; The total liabilities were 5229674 million yuan, a year-on-year increase of 22.51%; The net assets attributable to shareholders of listed companies were 7913847 million yuan, a year-on-year increase of 9.80%.
(I) at the end of the period, the total assets of the company were 13301746 million yuan, with a year-on-year increase of 14.42%, including:
Unit: 10000 yuan
Proportion of the project as of December 31, 2021 (%)
Total assets 13301746 100.0011625488 100.00 14.42
Current assets 9564461 71.908634067 74.27 10.78
Non current assets 372.85 28.102991421 25.73 24.93
Major asset items with significant changes are as follows:
1. The monetary capital at the end of the reporting period was 4193047 million yuan, an increase of 373021 million yuan over the beginning of the period, with an increase rate of 9.76%, mainly due to the increase of sales scale and collection in the current period.
2. The accounts receivable at the end of the reporting period was 361350500 yuan, an increase of 40798700 yuan over the beginning of the period, with an increase rate of 12.73%, mainly due to the increase in sales revenue and the corresponding increase in accounts receivable in the current period. 3. Other receivables at the end of the reporting period were 2.5501 million yuan, a decrease of 1.8491 million yuan compared with the beginning of the period, with an increase rate of – 42.03%, mainly due to the recovery of deposit and margin in the current period.
4. The prepayment at the end of the reporting period was 195987 million yuan, an increase of 123354 million yuan over the beginning of the period, with an increase rate of 169.83%, mainly due to the increase of prepayment in the current period.
5. Other current assets at the end of the reporting period were 1.8505 million yuan, an increase of 1.2474 million yuan over the beginning of the period, with an increase rate of 206.83%, mainly due to the increase of intermediary expenses for issuing convertible bonds in the current period.
6. The fixed assets at the end of the reporting period were 1196111 million yuan, an increase of 6.4328 million yuan over the beginning of the period, with an increase rate of 5.68%, mainly due to the increase in R & D equipment investment in the current period and the transfer of fixed assets from some sporadic projects.
7. The construction in progress at the end of the reporting period was 1521757 million yuan, an increase of 679497 compared with the beginning of the period
Million yuan, an increase rate of 80.68%, mainly due to the increase in investment in the company’s production line expansion project and gossypol acetate and traditional Chinese medicine decoction pieces project.
8. The right to use assets at the end of the reporting period was 3.2538 million yuan, an increase of 3.2538 million yuan over the beginning of the period
Million yuan, mainly due to the recognition of the leased house as the right to use asset according to the new leasing standards.
9. The deferred income tax assets at the end of the reporting period were 202044 million yuan, an increase of 3.7396 million yuan over the beginning of the period, with an increase rate of 22.86%, mainly due to the increase of academic promotion expenses accrued with the growth of business scale.
(II) total liabilities were 5229674 million yuan, with a year-on-year increase of 22.51%, including:
Unit: 10000 yuan
Proportion of the project as of December 31, 2021 (%)
Liabilities 5229674 100.004268862 100.00 22.51
Current liabilities 4375549 83.673441798 80.63 27.13
Non current liabilities 854125 16.33827064 19.37 3.27
Major liability items with large changes are as follows:
1. The short-term loan at the end of the reporting period was 50 million yuan, an increase of 400.29% over the beginning of the period,
It is mainly due to the increase of bank working capital loans in the current period.
2. The accounts payable at the end of the reporting period was 66.080 million yuan, an increase of 7.2 million yuan over the beginning of the period, with an increase rate of 12.24%, mainly due to the increase of engineering equipment payables for projects under construction in the current period.
3. The amount received in advance at the end of the reporting period was 190100 yuan, a decrease of 196600 yuan and an increase of
The growth rate was – 51.22%, mainly due to the decrease of rent received in advance in the current period.
4. The payroll payable at the end of the reporting period was 107623 million yuan, an increase of 275.25% over the beginning of the period
Million yuan, with an increase rate of 34.36%, mainly due to the increase of wages and bonuses with the growth of business during the reporting period, which has not been paid at the end of the period.
5. Other payables at the end of the reporting period were 258854300 yuan, an increase of 19639600 yuan over the beginning of the period, with an increase rate of 8.21%, mainly due to the increase of marketing expenses payable at the end of the period with the growth of business scale.
6. The contract liabilities at the end of the reporting period were 4.6968 million yuan, an increase of 2.6749 million yuan over the beginning of the period, with an increase rate of 132.29%, mainly due to the fact that the advance payment for goods has not fulfilled the obligation of goods delivery.
7. The non current liabilities due within one year at the end of the reporting period were 15.027 million yuan, an increase of 15.027 million yuan compared with the beginning of the reporting period, mainly due to the reclassification of long-term loans due within one year.
8. The long-term loan at the end of the reporting period was 40.35 million yuan, a decrease of 24.37% compared with the beginning of the reporting period, mainly due to the reclassification of long-term loans due within one year.
9. The deferred income at the end of the reporting period was 413951 million yuan, an increase of 138659 million yuan over the beginning of the period, with an increase rate of 50.37%, mainly due to the increase of government subsidies related to assets in the current period.
10. At the end of the reporting period, the lease liability was 1.316 million yuan, an increase of 1.131 million yuan compared with the beginning of the period, which was mainly due to the recognition of lease payments as lease liabilities in accordance with the new standards.
(III) the total owner’s equity attributable to the parent company was 7913847 million yuan, with a year-on-year increase of 9.80%, including:
Unit: 10000 yuan
Proportion of the project as of December 31, 2021 (%)
Owner’s equity attributable to parent 7913847 100.007207770 100.00 9.80
Share capital 866700 10.95866700 11.78 0.00
Capital reserve 2716729 34.332713039 37.64 0.14
Less: treasury shares 301488 3.81200470 2.78 50.39
Surplus reserve 474243 5.99399288 5.54 18.77
Undistributed profit 4157664 52.543429213 47.58 21.24
1. The share capital at the end of the reporting period was 86.67 million yuan, unchanged from the beginning of the period.
2. The capital reserve at the end of the reporting period was 271672900 yuan, an increase of 369000 yuan over the beginning of the period, mainly due to the acquisition of 41% equity of minority shareholders of Panlong Yunkang, a subsidiary in the current period.
3. The surplus reserve at the end of the reporting period was 474243 million yuan, an increase of 7.4954 million yuan over the beginning of the period, with an increase rate of 18.77%, mainly due to the withdrawal of legal surplus reserve in the current period.
4. The undistributed profit at the end of the reporting period was 415766400 yuan, an increase of 728451 million yuan over the beginning of the period, with an increase rate of 21.24%, mainly due to the undistributed profit carried forward after the net profit was withdrawn from the surplus reserve in the current period.
5. At the end of the reporting period, the treasury stock was 301488 million yuan, an increase of 101018 million yuan over the beginning of the period, with an increase rate of 50.39%, mainly due to the increase of share repurchase in the current period.
4、 Operating results in 2021
Unit: 10000 yuan
Increase and decrease of the project from 2021 to 2020
Operating income 88748496703130 32.40%
Operating profit 1125250949779 18.48%
Total profit 1090294944969 15.38%
selling expenses
